Senegal: trial of intermittent malaria treatment in children leads to 86% reduction in cases
A team of researchers from the London School of Hygiene & Tropical Medicine, working in partnership with colleagues from Senegal, has found that intermittent preventive malaria treatment of children under five has a dramatic impact on malaria frequency.
In a randomised, placebo-controlled trial, 1,136 children aged between two months and five years received either intermittent preventive treatment, consisting of one dose of artesunate plus one dose of sulfadoxine-pyrimethamine, or two placebos. The preventative treatments were carried out on three occasions during the malaria transmission season, in a health-care centre in Niakhar, a rural area of Senegal.
During thirteen weeks of follow up, the intervention led to an 86% reduction in the frequency of clinical episodes of malaria. The incidence of malaria in children with active drugs was 308 episodes per 1,000 person-years at risk, whereas in controls it was 2,250 episodes per 1,000 person-years at risk. The preventative treatment was safe and did not result in children who had received it experiencing more malaria episodes the following year.
According to the World Health Organisation, 90% of deaths from malaria occur in Africa, mostly in children under 5 years of age. In Senegal, the yearly mortality rate from malaria in children has increased substantially since the beginning of the 1990s, due in large part to growing resistance to standard malaria treatments. In addition to developing new malaria drugs there is a need to develop new ways of preventing the disease.
Dr Badara Cisse, a PhD student of the London School of Hygiene & Tropical Medicine (LSHTM) who is now based at the University of Dakar, Senegal, was principal investigator of the trial, and first author of the study, which appears in the February 25 issue of The Lancet. He is a one of 33 research degree students, mostly from malaria-endemic countries, to have been trained under the Capacity Development component of the Gates Malaria Partnership, which aims to strengthen research capability in the field of malaria.
Dr Cisse comments: ‘Seasonal intermittent preventive treatment is simple, cheap and dramatic in its impact on malaria in children under five in areas of seasonal malarial transmission. The results of this trial are very encouraging, but we do need to carry out further studies into whether the treatment can be delivered on a bigger scale. If we are to ensure higher rates of coverage, then we need to bring the whole community on board. There is also the question of what the effect might be on drug resistance, which needs to be further explored’.
Lindsay Wright | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...